Microcurrent stimulation in the treatment of dry and wet macular degeneration

Figures & data

Figure 1 Patient receiving microcurrent treatment.

Figure 2 Dry AMD eyes: absolute logMAR differences from starting values for each patient, plotted over first 3 months only.

Notes: Each color represents a different eye. There is an additional dotted axis line drawn at 0.
Abbreviations: AMD, age-related macular degeneration; logMAR, log of the minimum angle of resolution.

Figure 3 Wet AMD eyes: absolute logMAR differences from starting values for each patient, plotted over first 3 months only.

Notes: Each color represents a different eye. There is an additional dotted axis line drawn at 0.
Abbreviations: AMD, age-related macular degeneration; logMAR, log of the minimum angle of resolution.

Figure 4 Dry AMD eyes: mean absolute logMAR differences from starting values with 95% confidence intervals on these means.

Notes: Dotted lines represent the 95% confidence limits on the mean.
Abbreviations: AMD, age-related macular degeneration; logMAR, log of the minimum angle of resolution.

Figure 5 Wet AMD eyes: mean absolute logMAR differences from starting values with 95% confidence intervals on these means.

Notes: Dotted lines represent the 95% confidence limits on the mean.
Abbreviations: AMD, age-related macular degeneration; logMAR, log of the minimum angle of resolution.

Table 1 VA results for dry AMD

Eye no	Pretreatment VA	Posttreatment VA
1	20/40	20/20−
2	20/50	20/25−2
3	20/200	20/200
4	HM 1′	HM 1′
5	20/800+	20/640−
6	20/320+	20/160+
7	20/125+	20/63−
8	20/25−	20/30+
9	20/80	20/80−
10	20/200−	20/80−
11	20/20	20/20+
12	20/40−	20/32+
13	20/100−	20/70+
14	CF at 4′	CF at 4′
15	20/50−	20/50
16	20/200	20/200
17	20/60	20/50
18	20/100	20/30−
19	20/250+	20/50−
20	20/80+	20/60−
21	20/125−	20/125−
22	20/60−	20/50−
23	20/400	20/160
24	20/800	20/800
25	20/1,000	20/1,000+

Abbreviations: AMD, age-related macular degeneration; CF, count fingers; HM, hand motion; VA, visual acuity.

Table 2 VA results for wet AMD

Eye no	Pretreatment VA	Posttreatment VA
1	20/160−1	20/100+1
2	20/200	20/80−
3	20/60−	20/60+
4	20/70	20/50−
5	20/1,000+	20/800
6	20/100−	20/80−

Abbreviations: AMD, age-related macular degeneration; VA, visual acuity.

Figure 6 Dry AMD eyes: total letter change.

Notes: Blue = improvement, red = deterioration, and green = no change.
Abbreviation: AMD, age-related macular degeneration.

Figure 7 Wet AMD eyes: total letter change.

Notes: Blue = improvement, red = deterioration (no eyes deteriorated in this instance), and green = no change.
Abbreviation: AMD, age-related macular degeneration.

Figure 8 Pre- and post-microperimetry fields on three patients.

Notes: MP-1 fields of patient 16: (A) pretreatment, (B) following two treatments, and (C) after five treatments at 6 months.
Abbreviation: MP-1, microperimeter-1.

Figure 9 Pre- and post-microperimtery fields on two patients.

Notes: MP-1 fields of patient 17: (A) pretreatment and (B) posttreatment after three treatments.
Abbreviation: MP-1, microperimeter-1.